Sanofi
$39.92Change from previous close: −1.84%Absolute change: −$0.75
At a glance
- Revenue growth
- +5.49%
- 2025 vs 2024
- Net income growth
- +40.52%
- 2025 vs 2024
- Net margin
- 16.7%
- 2024: 12.6%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 | 7,418 | 7,715 | 5,547 | 7,379 | 7,838 |
| Depreciation and amortization | 3,257 | 3,111 | 3,247 | 3,053 | 3,001 | 3,186 | 3,593 | 3,339 | 3,007 | 2,841 |
| Capital expenditure | -1,762 | -1,733 | -1,619 | -1,529 | -1,478 | -1,254 | -1,323 | -1,415 | -1,388 | -1,219 |
| Investing cash flow | -2,447 | -4,407 | -6,200 | -2,075 | -7,298 | 3,619 | -1,183 | -12,866 | -2,896 | -2,511 |
| Financing cash flow | -8,207 | -5,763 | -8,052 | -5,821 | -7,056 | -6,485 | -4,039 | 3,928 | -4,367 | -4,101 |
| Dividends paid | -4,772 | -4,704 | -4,454 | -4,168 | -4,008 | -3,937 | -3,834 | -3,773 | -3,710 | -3,759 |
| Share repurchases | -5,030 | -302 | -593 | -497 | -382 | -822 | -9.0 | -1,101 | -2,162 | -2,908 |
| Debt issued | 5,559 | 59.0 | 799 | 1,765 | — | 2,301 | 1,997 | 9,677 | 71.0 | 4,869 |
| Debt repaid | -4,055 | -953 | -3,936 | -2,998 | -2,804 | -4,186 | -2,488 | -955 | -2,368 | -2,576 |
| Effect of exchange rates | -47.0 | -13.0 | -32.0 | 8.0 | 15.0 | -64.0 | 9.0 | 1.0 | -74.0 | -101 |
| Net change in cash | 216 | -1,269 | -4,026 | 2,638 | -3,817 | 4,488 | 2,502 | -3,390 | 42.0 | 1,125 |
| Free cash flow | 8,988 | 7,348 | 8,639 | 8,997 | 9,044 | — | — | — | — | — |
| Levered free cash flow | 16,643 | -4,944 | 7,172 | 8,514 | 7,336 | 6,284 | 5,110 | 4,168 | 10,834 | 5,747 |